1. Factors associated with mortality or transplantation versus Fontan completion after cavopulmonary shunt for patients with tricuspid atresia
- Author
-
Connor P. Callahan, Anusha Jegatheeswaran, David J. Barron, S. Adil Husain, Pirooz Eghtesady, Karl F. Welke, Christopher A. Caldarone, David M. Overman, James K. Kirklin, Marshall L. Jacobs, Linda M. Lambert, William M. DeCampli, Brian W. McCrindle, Aaron M. Abarbanell, Peter J. Gruber, Tara Karamlou, Linda Lambert, David B. Meyer, Christian Pizarro, Karthik Ramakrishnan, James D. St Louis, and Varsha Zadokar
- Subjects
Male ,Pulmonary and Respiratory Medicine ,congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Fontan Procedure ,Risk Assessment ,Tricuspid Atresia ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Mitral valve ,medicine.artery ,medicine ,Humans ,Prospective Studies ,cardiovascular diseases ,Tricuspid atresia ,Mitral valve repair ,business.industry ,Heart Bypass, Right ,Hazard ratio ,Infant ,medicine.disease ,Transplantation ,Treatment Outcome ,surgical procedures, operative ,medicine.anatomical_structure ,030228 respiratory system ,Great vessels ,Pulmonary artery ,cardiovascular system ,Cardiology ,Heart Transplantation ,Female ,Surgery ,Cardiology and Cardiovascular Medicine ,Mitral valve regurgitation ,business - Abstract
OBJECTIVE Tricuspid atresia with normally related great vessels (TA) is considered the optimal substrate for the Fontan pathway. The factors associated with death or transplantation after cavopulmonary shunt (CPS) are underappreciated. We aimed to determine factors associated with CPS-Fontan interstage death/transplantation versus transition to Fontan in TA. METHODS A total of 417 infants younger than 3 months of age with TA were enrolled (January 1999 to February 2020) from 40 institutions into the Congenital Heart Surgeons' Society TA cohort. Parametric competing risk methodology was used to determine factors associated with the competing end points of death/transplantation without Fontan completion, and transition to Fontan. RESULTS CPS was performed in 382 patients with TA; of those, 5% died or underwent transplantation without transition to Fontan and 91% transitioned to Fontan by 5 years after CPS. Prenatal diagnosis (hazard ratio [HR], 0.74; P
- Published
- 2022
- Full Text
- View/download PDF